Continence (Sep 2023)
INTERSTIMTM MICRO IMPROVES SYMPTOMS AND PATIENT-REPORTED OUTCOMES IN SUBJECTS WITH NON-OBSTRUCTIVE URINARY RETENTION AT 3-MONTH FOLLOW-UP
- C Goudelocke,
- V Lavin,
- M Perrouin-Verbe,
- D Elterman,
- B Peyronnet,
- M Smits,
- S Shah,
- K Xavier,
- R Krlin,
- R Bukkapatnam,
- B Papi,
- E Gillespie,
- A Sahai,
- S Malde
Affiliations
- C Goudelocke
- Department of Urology, Ochsner Medical Center, New Orleans LA, USA
- V Lavin
- The Newcastle upon Tyne Hospitals NHS Foundation Trust – Freeman Hospital, UK
- M Perrouin-Verbe
- Department of Urology, Centre Hospitalier Universitaire de Nantes, Nantes, France
- D Elterman
- Division of Urology, University of Toronto, Toronto, Canada
- B Peyronnet
- Department of Urology, Centre Hospitalier Universitaire de Rennes, Rennes, France
- M Smits
- Maastricht Universitair Medisch Centrum, Maastricht, Netherlands
- S Shah
- East Coast Institute for Research LLC, Jacksonville FL, USA
- K Xavier
- Urology Partners of North Texas, Arlington TX, USA
- R Krlin
- Department of Urology, Louisiana State University Health Sciences Center, New Orleans LA, USA
- R Bukkapatnam
- Florida Urology Partners, Tampa, FL, USA
- B Papi
- Medtronic, Minneapolis MN, USA
- E Gillespie
- Medtronic, Minneapolis MN, USA
- A Sahai
- Guys & St Thomas NHS FDN Trust-St Thomas, London, UK
- S Malde
- Guys & St Thomas NHS FDN Trust-St Thomas, London, UK
- Journal volume & issue
-
Vol. 7
p. 100934